Cencora announced that a portion of Walgreens' volume, separate from their prime vendor agreement, will move outside Cencora starting July 1, 2026. Despite this shift, Cencora reaffirmed its FY26 adjusted diluted EPS guidance, suggesting the impact was already factored into their outlook, mitigating immediate negative market reaction.
Cencora disclosed that 'certain Walgreens volume' will no longer be serviced by them starting July 1, 2026. This volume is distinct from the 'prime vendor agreement,' which remains unchanged and represents the vast majority of their business with Walgreens. The key takeaway is that Cencora has reaffirmed its FY26 adjusted diluted EPS guidance, indicating that this change was 'fully contemplated' in their August 5, 2026 commentary. This suggests the market impact for Cencora (COR) should be limited, as the financial implications are already baked into their forward-looking statements. For Walgreens (WBA), this indicates a potential diversification of their supply chain or a shift to other distributors for specific product lines, but the core relationship with Cencora remains intact. Traders should note that while the headline might initially sound negative, the reaffirmation of guidance significantly de-risks the announcement for Cencora.